Skip to content
value.today

Gestalt Diagnostics, LLC

🇺🇸 Spokane, Washington, USAHealth CareFounded 2015
Total raised
$9 M
2 rounds on record
Latest round
$7 M
Mar 2025
First round on record
Feb 2017
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Gestalt Diagnostics, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2025$7 MNo. 2$2 to $10 million

Gestalt Diagnostics, LLC: Raise no. 2, Mar 2025

Investors in this round

29 investors had bought by the notice of Jul 7, 2025: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $9 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Dan Roark · Executive Officer, Director, Promoter
  • Steve Rector · Executive Officer
  • Bill Driscoll · Director
  • Chris Patrick · Director
  • Octavio Morales · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “includes (i) principal and interest on convertible notes in the amount of $4,253,803, and (ii) $5,000,000 new money”

Signed by Dan Roark, President and CEO. Newest notice filed Jul 7, 2025. Read the notice at the SEC.

equitySEC
Feb 2017$3 MNo. 1$2 to $10 million

Gestalt Diagnostics, LLC: Raise no. 1, Feb 2017

Investors in this round

39 investors had bought by the notice of Mar 10, 2017: 39 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered; $0 M still to sell
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$275,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Washington

People named in the notice

  • Dan Roark · Executive Officer
  • Ken McCabe · Executive Officer, Director
  • Jon Copeland · Director
  • Marco Chung · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Dan Roark, Chief Executive Officer. Newest notice filed Mar 10, 2017. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Gestalt Diagnostics, LLC chose not to state its revenue in its newest notice of a funding round (Jul 2025).

    SEC Form D · Jul 2025

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Gestalt Diagnostics, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Gestalt Diagnostics, LLC
NameRoleNamed in
Dan RoarkExecutive officerJul 2025
Steve RectorExecutive officerJul 2025
Ken McCabeExecutive officerMar 2017
Bill DriscollDirectorJul 2025
Chris PatrickDirectorJul 2025
Dan RoarkDirectorJul 2025
Octavio MoralesDirectorJul 2025
Jon CopelandDirectorMar 2017
Ken McCabeDirectorMar 2017
Marco ChungDirectorMar 2017
Dan RoarkPromoterJul 2025